More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Vimentin antibody

Vimentin antibody

GTX112661
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
DownloadDatasheet
Product group Antibodies
ReactivityHuman
TargetVIM
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    Vimentin antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.95 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID7431
  • Target name
    VIM
  • Target description
    vimentin
  • Target synonyms
    epididymis secretory sperm binding protein; vimentin
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP08670
  • Protein Name
    Vimentin
  • Scientific Description
    Along with the microfilaments (actins) and microtubules (tubulins), the intermediate filaments represent a third class of well-characterized cytoskeletal elements. The subunits display a tissue-specific pattern of expression. Desmin (MIM 125660) is the subunit specific for muscle and vimentin the subunit specific for mesenchymal tissue.[supplied by OMIM]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Novel insights into PORCN mutations, associated phenotypes and pathophysiological aspects. Arlt A et al., 2022 Jan 31, Orphanet J Rare Dis
    Read more
  • Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells. Yen YT et al., 2021 Dec 28, Int J Mol Sci
    Read more
  • MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme. Pan CM et al., 2020 Nov 28, Cancer Lett
    Read more
  • Agonist of PPAR-gamma Reduced Epithelial-Mesenchymal Transition in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps via Inhibition of High Mobility Group Box1. Yang P et al., 2019, Int J Med Sci
    Read more
  • ResolvinD1 attenuates high-mobility group box 1-induced epithelial-to-mesenchymal transition in nasopharyngeal carcinoma cells. Yang P et al., 2019 Dec, Exp Biol Med (Maywood)
    Read more
  • Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCalpha-mediated AHR-HDAC interactions. Tsai CH et al., 2020 Feb, Biochim Biophys Acta Mol Cell Res
    Read more
  • miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH et al., 2019 Sep, Pharmacol Res
    Read more
  • Upregulation of LGALS1 is associated with oral cancer metastasis. Li JM et al., 2018, Ther Adv Med Oncol
    Read more
  • Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia. Terasaki M et al., 2018 Apr, Anticancer Res
    Read more
  • Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5. Chen CY et al., 2018 Jan 27, Int J Mol Sci
    Read more